U.S. Auto Stock News

NYSE:HPQ
NYSE:HPQTech

HP (HPQ) Valuation Check After CEO Departure And Ongoing Operational Challenges

HP (HPQ) is back in focus after Enrique Lores stepped down as CEO and President, and board member Bruce Broussard became Interim CEO as the company starts a formal search for a permanent leader. See our latest analysis for HP. At a share price of US$19.43, HP has seen a 22.93% decline in its 90 day share price return and a 38.79% drop in its 1 year total shareholder return. This suggests momentum has been fading even as the company reaffirmed 2026 earnings guidance, updated its bylaws and...
NasdaqGS:PFG
NasdaqGS:PFGInsurance

Assessing Principal Financial Group (PFG) Valuation After Recent Share Price Pullback

Recent performance snapshot Without a single headline event setting the tone, Principal Financial Group (PFG) has still given investors a fair amount to think about, with the shares recently closing at $95.93. The stock shows a 1 day return of a 1.45% decline, while the past week is slightly positive at 0.67%. Over the past month and past 3 months, returns of 6.25% and 12.51% highlight a different picture from the near term move. See our latest analysis for Principal Financial Group. That...
NYSE:HOG
NYSE:HOGAuto

Is It Time To Reconsider Harley-Davidson (HOG) After Recent Share Price Weakness?

If you are wondering whether Harley-Davidson is quietly turning into a value story, the stock's recent performance gives you a starting point but not the full picture. The share price closed at US$20.14, with a 3.0% gain over the last 7 days, while the 30 day, year to date and 1 year returns of 6.0% decline, 2.4% decline and 19.6% decline show a tougher run over longer periods. Recent coverage has focused on Harley-Davidson's position as a long established motorcycle brand and how sentiment...
NYSE:BDX
NYSE:BDXMedical Equipment

Becton Dickinson Refocuses On Medtech After Waters Spin Off And Buyback

Becton Dickinson (NYSE:BDX) has completed a $17.5b spin off and merger of its Biosciences and Diagnostic Solutions businesses with Waters. The deal restructures Becton Dickinson as a more focused medtech company and is paired with a new capital allocation plan. The company reported strong Q1 results alongside the announcement of a $2b share repurchase program and debt reduction plans. Becton Dickinson, trading around $207.39, is reshaping itself around its core medtech operations after this...
NYSE:ATKR
NYSE:ATKRElectrical

Atkore (ATKR) Valuation Check After Sharp Earnings And Profitability Declines

Q1 earnings put Atkore’s recent performance in focus Atkore (ATKR) has come under closer scrutiny after first quarter results showed sales of US$655.55 million versus US$661.6 million a year earlier, with net income at US$15.03 million compared with US$46.34 million. See our latest analysis for Atkore. The weaker first quarter result comes after a period where short-term share price momentum has faded, with a 7-day share price return showing a decline of 4.81% and a 1-year total shareholder...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

What Amneal Pharmaceuticals (AMRX)'s Index Additions and Opioid Settlement Mean For Shareholders

Amneal Pharmaceuticals, Inc. was recently added to the S&P 1000, S&P Composite 1500, S&P 600, and S&P 600 Health Care indices, while also making effective on January 29, 2026, a nationwide opioid settlement that includes US$88.5 million in cash payments and up to US$177.4 million in naloxone nasal spray over ten years. This combination of index inclusions and a broad opioid settlement materially reshapes Amneal’s profile by widening its investor base and reducing legal uncertainty with...
NYSE:SNOW
NYSE:SNOWIT

Snowflake Deepens AI Ambitions With OpenAI Deal And New Sector Tools

Snowflake (NYSE:SNOW) announced a multi-year partnership with OpenAI to bring models such as GPT-5.2 directly into its Cortex AI platform. The collaboration focuses on co-developing enterprise AI tools, including custom AI agents, with built-in governance and security controls. Snowflake also introduced new AI driven products like Cortex Code and Semantic View Autopilot, plus new industry offerings, including Energy Solutions. Snowflake is trading at $175.95, with returns of 8.6% over 3...
NYSE:GL
NYSE:GLInsurance

Globe Life (GL) Valuation Check As Strong Earnings And Bullish Analyst Outlook Draw Fresh Attention

Globe Life (GL) has drawn fresh attention after reporting fourth quarter and full year 2025 results, along with an updated outlook that included higher earnings guidance and an additional analyst update following the release. See our latest analysis for Globe Life. Globe Life’s latest earnings, share repurchases and fresh analyst commentary have arrived after a steady run. The share price closed at US$141.42 with a 1 year total shareholder return of 16.63%, while the 90 day share price return...
NYSE:DAR
NYSE:DARFood

Assessing Darling Ingredients (DAR) Valuation As Earnings Optimism And Analyst Upgrades Drive Recent Rally

Darling Ingredients (DAR) is back in focus this week as investors watch for Wednesday’s after hours earnings report, following last quarter’s revenue beat and stronger than expected adjusted operating income performance. See our latest analysis for Darling Ingredients. At a share price of $48.40, Darling Ingredients has seen a 23.85% 1 month share price return and a 41.07% 3 month share price return. The 1 year total shareholder return of 22.22% contrasts with weaker 3 and 5 year total...
NasdaqGS:LI
NasdaqGS:LIAuto

Is Li Auto’s (LI) January Deliveries Milestone Redefining Its Core EV Growth Narrative?

Li Auto Inc. reported that it delivered 27,668 vehicles in January 2026, bringing its cumulative deliveries to 1.57 million as of January 31, 2026. This milestone underscores how monthly delivery volumes have become a central operational yardstick for assessing Li Auto’s progress in the electric vehicle market. We will now examine how Li Auto’s January delivery performance shapes the company’s investment narrative and future growth considerations for investors. Invest in the nuclear...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

A Look At Qualcomm (QCOM) Valuation As Handset Guidance Softens On Supply And China Demand Headwinds

QUALCOMM (QCOM) is back in focus after first quarter results and fresh guidance pointed to pressure in its core handset business, with memory chip shortages and softer Chinese demand weighing on the near term outlook. See our latest analysis for QUALCOMM. Those handset concerns have fed directly into recent trading, with the share price at US$138.93 after a 1-day share price return of 1.16% but a 30-day share price return decline of 21.85% and a year-to-date share price return decline of...
NasdaqCM:STEX
NasdaqCM:STEXMedical Equipment

Assessing Streamex (STEX) Valuation After Recent Leadership Changes And Shifting Shareholder Returns

Streamex (STEX) is back on investors’ radar after a pair of leadership changes, with co founder Morgan Lekstrom becoming Executive Chairman and NYU finance professor Anthony Marciano joining the board and Audit Committee. See our latest analysis for Streamex. Those boardroom changes arrive after a sharp run, with a very large 1 year total shareholder return contrasting with a 3 year total shareholder return that is still down 78%, and recent share price weakness, including a 90 day share...
NasdaqGS:CYBR
NasdaqGS:CYBRSoftware

A Look At CyberArk Software (CYBR) Valuation As Earnings Highlight Revenue Growth And A Smaller Net Loss

Earnings report puts CyberArk Software (CYBR) in focus CyberArk Software (NasdaqGS:CYBR) is back on investors’ radar after its latest earnings release, which paired higher fourth quarter and full year 2025 revenue with a much smaller quarterly net loss. See our latest analysis for CyberArk Software. The earnings release and upcoming WEST Conference appearance have arrived after a weaker patch for the stock. The 30 day share price return is 10.40% and the 90 day share price return is 20.85%,...
NasdaqGS:GEN
NasdaqGS:GENSoftware

Gen Digital (GEN) Valuation Check After Revenue Growth And New AI Security Offerings

Gen Digital (GEN) has been busy, combining higher reported revenue and a growing customer base with new AI focused security offerings such as the Gen Agent Trust Hub and Norton Neo, along with dividend and buyback activity. See our latest analysis for Gen Digital. At a share price of $24.60, Gen Digital has seen a 9.58% 7 day share price return after a weaker 30 and 90 day period, while its 3 and 5 year total shareholder returns remain positive, hinting that recent momentum is picking up...
NYSE:VNO
NYSE:VNOOffice REITs

Assessing Vornado Realty Trust (VNO) Valuation After Recent Share Price Weakness

Why Vornado Realty Trust is on investors’ radar today Vornado Realty Trust (VNO) is drawing attention after its recent trading performance, with the stock reflecting mixed short term returns and a value score that may prompt closer scrutiny from income and real estate focused investors. See our latest analysis for Vornado Realty Trust. At a share price of US$30.99, Vornado’s recent 1-day share price return of a 0.90% decline and 30-day share price return of a 10.20% decline contrast with a...
NYSE:LMND
NYSE:LMNDInsurance

Assessing Lemonade (LMND) Valuation As Customer Growth And AI Plans Attract Fresh Investor Attention

Lemonade (LMND) is back in focus after revealing that its customer base nearly tripled between 2020 and the third quarter of 2025, along with plans to expand premiums and refine its AI-driven insurance platform. See our latest analysis for Lemonade. The latest customer growth plans are playing out against a choppy share price backdrop, with a 1-day share price return of a 2% decline and a 7-day share price return of a 12% decline. At the same time, the 1-year total shareholder return of 122%...
NYSE:VMI
NYSE:VMIConstruction

How Investors Are Reacting To Valmont Industries (VMI) Balancing Softer Sales With Precision Agriculture Investment

Valmont Industries recently reported quarterly results showing slightly softer revenue but preserved profitability through cost controls and improved business mix, while continuing to invest in precision agriculture technology and grid reliability solutions. This combination of earnings resilience and commitment to long-term infrastructure and agriculture themes has focused investor attention on how the company is positioning its portfolio. Next, we’ll examine how this emphasis on precision...
NYSE:DT
NYSE:DTSoftware

February 2026's Noteworthy Stocks Estimated Below Intrinsic Value

As February 2026 begins, U.S. stock markets have shown a strong start with major indices like the Dow Jones and S&P 500 ending sharply higher, reflecting investor optimism despite ongoing geopolitical and economic uncertainties. In this environment of fluctuating market dynamics and evolving trade agreements, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on discrepancies between market price and intrinsic value.
NYSE:RNG
NYSE:RNGSoftware

Insider Favorites Rumble And Two Other Growth Stocks

As the U.S. stock market begins February on a high note, with major indices like the Dow Jones Industrial Average and S&P 500 posting significant gains, investors are keenly observing growth companies that exhibit strong insider ownership. In this thriving market environment, stocks with substantial insider stakes can often signal confidence in the company's potential, making them appealing options for those looking to align their investments with insiders who have a vested interest in the...
NasdaqGS:API
NasdaqGS:APISoftware

February 2026's Promising Penny Stocks To Consider

As February 2026 begins, the U.S. stock market has seen a robust start, with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains. This positive momentum reflects broader economic optimism and renewed investor confidence, despite ongoing geopolitical developments and economic policy shifts. In this context, penny stocks—often representing smaller or newer companies—continue to capture interest for their potential to offer growth opportunities at an...
NasdaqCM:RDVT
NasdaqCM:RDVTSoftware

Discovering 3 Undiscovered Gems in the US Market

As February begins, the U.S. stock market has shown robust performance with major indices like the Dow Jones and S&P 500 experiencing significant gains, reflecting a positive start to the month despite recent economic uncertainties such as government shutdowns and trade negotiations. In this dynamic environment, identifying promising small-cap stocks can offer unique opportunities for investors seeking growth potential; these undiscovered gems often thrive by capitalizing on niche markets or...
NasdaqCM:OSPN
NasdaqCM:OSPNSoftware

Three Noteworthy Dividend Stocks To Consider

As February begins, U.S. stock markets have surged, with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. In this dynamic market environment, dividend stocks can offer investors a blend of income stability and potential growth, making them an attractive consideration amidst fluctuating economic conditions.
NYSE:PATH
NYSE:PATHSoftware

A Look At UiPath (PATH) Valuation After Recent Share Price Weakness

With no single fresh headline moving UiPath (PATH) today, the recent share performance stands out, including a 20% decline over the past month and negative total returns over the past year and the past 3 months. See our latest analysis for UiPath. At a share price of $13.00, UiPath’s recent 7 day share price return of 3.67% contrasts with a 30 day share price decline of 20.34% and a 1 year total shareholder return of 8.64% in the red. This points to fading momentum as investors reassess...
NYSE:RVTY
NYSE:RVTYLife Sciences

Revvity Expands Automation Platforms At SLAS2026 As Investors Weigh Long Term Upside

Revvity (NYSE:RVTY) introduced several new discovery and automation platforms at SLAS2026. The company showcased the Opera Phenix OptIQ high content screening system, EnVision Nexus One plate reader, and AssayMate workstation. Revvity also highlighted collaborations around automated next generation sequencing workflows at the event. Revvity, which focuses on life science tools and diagnostics, is pushing deeper into high throughput drug discovery and lab automation with these SLAS2026...